ArticleJournal of neurovirology2008
Hybrid baculovirus-adeno-associated virus vectors for prolonged transgene expression in human neural cells.
Article in Journal of neurovirology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 10 citations in OpenAlex.
- Solutions against emerging infectious and noninfectious human diseases through the application of baculovirus technologies.Applied microbiology and biotechnology · 2021Review
- Highly efficient transduction of primary adult CNS and PNS neurons.Scientific reports · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To prolong the transient gene expression mediated by baculoviral vector, the inverted terminal repeats and Rep gene of adeno-associated virus were incorporated into the genome of baculovirus, creating a hybrid baculovirus-adeno-associated viral (AAV) vector. By using previously constructed composite neuron-specific and astrocyte-specific promoters in this hybrid viral vector, sustained transgene expressions could be achieved in human neuronal and glial cell lines, but not in the correspondent rodent cell lines. This hybrid baculovirus-AAV vector might be useful for gene therapy of chronic neurological diseases in the central nervous system, such as Parkinson's disease and Alzheimer's disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.